315 related articles for article (PubMed ID: 23184699)
1. Targeted approaches toward understanding and treating pulmonary lymphangioleiomyomatosis (LAM).
Hammes SR; Krymskaya VP
Horm Cancer; 2013 Apr; 4(2):70-7. PubMed ID: 23184699
[TBL] [Abstract][Full Text] [Related]
2. Smooth muscle-like cells in pulmonary lymphangioleiomyomatosis.
Krymskaya VP
Proc Am Thorac Soc; 2008 Jan; 5(1):119-26. PubMed ID: 18094094
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Strategies for Treatment of Pulmonary Lymphangioleiomyomatosis (LAM).
Krymskaya VP
Expert Opin Orphan Drugs; 2014 Oct; 2(10):1063-1074. PubMed ID: 26779398
[TBL] [Abstract][Full Text] [Related]
4. Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM).
Goncharova EA; Goncharov DA; Fehrenbach M; Khavin I; Ducka B; Hino O; Colby TV; Merrilees MJ; Haczku A; Albelda SM; Krymskaya VP
Sci Transl Med; 2012 Oct; 4(154):154ra134. PubMed ID: 23035046
[TBL] [Abstract][Full Text] [Related]
5. Clinical and molecular insights into lymphangioleiomyomatosis.
Steagall WK; Taveira-DaSilva AM; Moss J
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S49-66. PubMed ID: 16457017
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Lymphangioleiomyomatosis: A Case Report and Literature Review.
Sathirareuangchai S; Shimizu D; Vierkoetter KR
Hawaii J Health Soc Welf; 2020 Jul; 79(7):224-229. PubMed ID: 32666056
[TBL] [Abstract][Full Text] [Related]
7. Lymphangioleiomyomatosis: new concepts in pathogenesis, diagnosis, and treatment.
Meraj R; Wikenheiser-Brokamp KA; Young LR; McCormack FX
Semin Respir Crit Care Med; 2012 Oct; 33(5):486-97. PubMed ID: 23001803
[TBL] [Abstract][Full Text] [Related]
8. Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies.
Glasgow CG; Steagall WK; Taveira-Dasilva A; Pacheco-Rodriguez G; Cai X; El-Chemaly S; Moses M; Darling T; Moss J
Respir Med; 2010 Jul; 104 Suppl 1(Suppl 1):S45-58. PubMed ID: 20630348
[TBL] [Abstract][Full Text] [Related]
9. [Pulmonary lymphangioleiomyomatosis with or without tuberous sclerosis].
Urban T
Rev Mal Respir; 2007 Jun; 24(6):725-40. PubMed ID: 17632432
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary lymphangioleiomyomatosis (LAM): progress and current challenges.
Goncharova EA; Krymskaya VP
J Cell Biochem; 2008 Feb; 103(2):369-82. PubMed ID: 17541983
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.
Stepanova V; Dergilev KV; Holman KR; Parfyonova YV; Tsokolaeva ZI; Teter M; Atochina-Vasserman EN; Volgina A; Zaitsev SV; Lewis SP; Zabozlaev FG; Obraztsova K; Krymskaya VP; Cines DB
J Biol Chem; 2017 Dec; 292(50):20528-20543. PubMed ID: 28972182
[TBL] [Abstract][Full Text] [Related]
12. Rare lung diseases I--Lymphangioleiomyomatosis.
Juvet SC; Hwang D; Downey GP
Can Respir J; 2006 Oct; 13(7):375-80. PubMed ID: 17036091
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for Lymphangioleiomyomatosis and Tuberous Sclerosis: Progress and Future Directions.
Liu HJ; Krymskaya VP; Henske EP
Chest; 2019 Dec; 156(6):1062-1067. PubMed ID: 31437431
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2.
Maruyama H; Ohbayashi C; Hino O; Tsutsumi M; Konishi Y
Pathol Int; 2001 Aug; 51(8):585-94. PubMed ID: 11564212
[TBL] [Abstract][Full Text] [Related]
15. Lymphangioleiomyomatosis and tuberous sclerosis.
Hancock E; Tomkins S; Sampson J; Osborne J
Respir Med; 2002 Jan; 96(1):7-13. PubMed ID: 11863212
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary lymphangioleiomyomatosis in tuberous sclerosis. A case report.
De Rosa N
Pathologica; 2009 Oct; 101(5):186-9. PubMed ID: 20218060
[TBL] [Abstract][Full Text] [Related]
17. Lymphangioleiomyomatosis.
Xu KF; Xu W; Liu S; Yu J; Tian X; Yang Y; Wang ST; Zhang W; Feng R; Zhang T
Semin Respir Crit Care Med; 2020 Apr; 41(2):256-268. PubMed ID: 32279296
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.
Li C; Zhang E; Sun Y; Lee PS; Zhan Y; Guo Y; Osorio JC; Rosas IO; Xu KF; Kwiatkowski DJ; Yu JJ
PLoS One; 2014; 9(10):e104809. PubMed ID: 25347447
[TBL] [Abstract][Full Text] [Related]
19. Lymphangioleiomyomatosis and tuberous sclerosis complex.
Chorianopoulos D; Stratakos G
Lung; 2008; 186(4):197-207. PubMed ID: 18408969
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).
Urban T; Lazor R; Lacronique J; Murris M; Labrune S; Valeyre D; Cordier JF
Medicine (Baltimore); 1999 Sep; 78(5):321-37. PubMed ID: 10499073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
